Related Experiment Video
Updated: Jun 13, 2026
Application of a Dual Upper Limb Task-Oriented Robotic System for the Functional Recovery of the Upper Limb in Stroke Patients
Published on: October 11, 2024
Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group study
M Barnes1, A Schnitzler, L Medeiros
114 Rake House Farm, North Shields, UK. m.p.barnes@btinternet.com
Objective:
To assess efficacy and safety of two dilutions of botulinum neurotoxin type A NT 201 (Xeomin®) in patients with upper limb spasticity of diverse etiology.
Methods:
Changes in functional disability and muscle tone from baseline to week 4 after NT 201 treatment.
Results:
One hundred ninety-two patients with stroke, brain injury, multiple sclerosis, or cerebral palsy were randomized to either 50 or 20 U/ml NT 201 dilutions. The maximum total NT 201 dose was 495 units. Four weeks post-injection, a ≥ 1-point reduction was observed on the Disability Assessment Scale in 57.1%, and on the Ashworth scale in ≥ 62.2% of patients. The 20 U/ml NT 201 dilution was non-inferior to the 50 U/ml NT 201 dilution. Global improvement was rated high by patients (80.2%) and investigators (89.0%).
Conclusions:
NT 201 improved functional disability and muscle tone and was well tolerated in patients with upper limb spasticity of diverse etiology in both dilutions.
